Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5588_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
34 Мб
Скачать
Fig. 6 Applications of MNRs for precision medicine applications. (Reprinted from Soto F, Wang J, Ahmed R, Demirci U. Medical micro/nanorobots in precision medicine. Adv Sci 7 2020:2002203. 2020 Open-access, Wiley Online Library.)
bacterium that uses the urease enzymes in its body to change the pH of the surrounding environment to increase the viscosity of the fluid, thus facilitating its penetration [84]. These are just a few examples to describe how natural-occurring strategies are used for efficient locomotion at small scales.
From a technological perspective, propulsion mechanisms have high relevance to
each specific task performed. In fact, MNRs have been considered as dynamic platforms to deliver a large array of cargoes (e.g., pharmaceutical, biologic) by exploiting the same mechanisms that propel their structures, often in combination with other external stim­uli. In order to carry and release agents, MNRs take advantage of electrostatic or covalent interactions to hold them on their surfaces, or they are equipped with multistable struc­tures that are triggered by external stimuli (e.g., polarized light) or the variation in the environmental conditions (e.g., pH, temperature) [85–88].
After a description of the main propulsion mechanisms currently employed in MNRs, we describe the main drug delivery applications of synthetic MNRs for precision medicine. Many of the strategies reported above using NPs, could also comply with the MNR philosophy, once they are provided with a locomotion system.
115Biomaterials and devices for immunotherapy
5. Propulsion engines for MNRs
Locomotion in MNRs is mainly achieved by exploiting either the interaction with
an external source (exogenous-driven devices) or exploiting the results of an internal
116 Emily M. Jordan et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
chemical or biological reaction (endogenous engines) [89]. Specifically, the first group includes propulsion devices triggered by magnetic or electric fields [90,91] or solutions based on the exploitation of light or ultrasounds [92–94] (Fig. 7). The common require­ment for a propulsion engine is the ability to have sufficient autonomy to guide the device to its target with the lowest positioning error achievable, to efficiently perform the envisioned task (e.g., drug delivery) [95].
Magnetism is undoubtedly the most employed trigger to propel MNRs. Scientists have successfully employed magnetic fields to enable a helical or undulated motion to penetrate fluids [90,96]. Interestingly, it has been demonstrated that magnetic field­driven microengines can perform precise movements, even in living cells [97], with fields that are 1000 times weaker than a traditional magnetic resonance imaging (MRI) pro­cedure [98]. This approach originated from the solution developed by nature in billions of years of evolution that is still observable in bacteria or microorganisms that take advan­tage of flagella or flexible bundles. Synthetic applications usually combine helicoidal shapes with magnetic fields, whose directions and amplitudes ensure precise locomotion of the device [99,100] (Fig. 8). In contrast, Au-Ag-Ni nanowires have been used to create flexible bodies able to perform undulatory locomotion leading to a traveling wave. In this case, the different polarization of Au and Ni gives an asymmetry in the rotational ampli­tudes, creating a rototranslational motion de facto [101]. Authors have studied the loco­motion differences between one-, two-, and three-link magnetic structures, achieving a complete S-like movement only with the three-link device [102]. The last propulsion mechanism activated by magnetic fields is the so-called surface walking. Rotating Ni nanowires of colloidal microwheels are positioned onto MNRs to enable movements on top of surfaces [103,104].
Electricity is an energy source that is strictly connected with magnetic field since they can mutually influence each other. Rotational electrical nanomotors have been designed
Fig. 7 Propulsion for MNRs: a classification.
Fig. 8 Magnetic MNRs. Panel A. Helicoidal MNR and in vitro tests to assess movements upon variable
magnetic fields. (Reprinted with permission Zhang L, Abbott JJ, Dong L, Kratochvil BE, Bell D, Nelson BJ. Artificial bacterial flagella: fabrication and magnetic control. Appl Phys Lett 2009;94:64107. © 2009 AIP Publishing.)
and employed in a large number of applications since electricity is easily accessible and can be manipulated to prevent damage to living tissues. As occurs for magnetic-field-driven engines, MNRs propelled by electricity have metallic components that may lead to health issues, while the main disadvantage consists in its weak penetration in tissues [105].
Light is an energy source that has been used more as a trigger for specific tasks rather than as a source to activate propulsion. Movement directionality depends on light fre­quency, polarization, intensity, and propagation direction [92]. However, within the light spectrum, visible light cannot penetrate tissues [105] while UV light allows good locomotion but causes harmful effects [106]. Only NIR light can penetrate tissues without causing health problems and therefore is the most promising in terms of both locomotion and task triggers [107,108].
The last exogenous source for MNRs is the energy given by ultrasounds that are usu­ally carried by gold nanowires [93]. The working principle is based on the exploitation of the pressure gradient generated by ultrasounds conveyed in a concave cavity of the MNR
[109]. Due to the impossibility of steering an MNR with ultrasounds, magnetic fields are
usually employed to change the directionality of the movement [110]. However, in con­trast to other propulsion systems, ultrasound stimulation provides a fast and high­amplitude thrust that allows an efficient penetration of MNR into tissues and even cells
[105]. As the main disadvantage, oxidative stress has been observed in cells penetrated by
ultrasounds, a phenomenon that might damage the functionality of healthy tissues [111].
Endogenous-powered MNRs are designed as asymmetric structures that are coated with catalyzers in order to properly interact with the surrounding environment. As antic­ipated above, propulsion is achieved by converting the energy from a chemical reaction
117Biomaterials and devices for immunotherapy
118 Emily M. Jordan et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
(e.g., redox activity) into a driving force. The most employed method in vitro is the exploitation of the decomposition of hydrogen peroxide into water and oxygen through catalysts (e.g., enzymes, metals). However, from a clinical standpoint, the exploitation of hydrogen peroxide for in vivo applications is limited due to its nonneglectable toxicity and the nonbiodegradation of many MNRs [105]. Practicable alternatives are the employ- ment of magnesium that produces propelling bubbles when in contact with water
[112,113], or the use of biocompatible enzyme catalysis [114]. Endogenous-driven
MNRs have a great potential for drug delivery applications [115,116] but the main dis­advantages are the potential discontinuity of the movement ( e.g., the propulsion is not sufficient to propel the MNR up to its target), and the difficulty in controlling the direc­tionality of the movement that can be disturbed by ionic media [105].
6. Applications of MNRs
Among the wide range of applications in which MNRs have been employed, we focus on drug delivery for targeted immunotherapy and chemotherapy tasks. Applica­tions of MNRs are, thus, here reported using the propulsion system as a clustering method. Table 2 summarizes the main applications, advantages and disadvantages of each class of MNR.
6.1 Magnetic-driven MNRs
One of the first magnetic MNRs was developed a decade ago by using a catalytic nano­wire to release PLGA liposomes charged with Dox and iron oxide. Cargo release was achieved by a rapid change of direction of the magnetic field and passively helped by the induced drag forces [117]. Similar structures have been employed to carry and deliver liposomes with calcein that were adsorbed onto the surfaces of the material with electro­static forces [118,119]. A magnetic MNR was developed by Qiu et al. that uses a temperature-sensitive liposome coating on a magnetism-driven titanium structure, to deliver drugs upon temperature regulation. With this MNR, the authors achieved a 73% 15% correct release of calcein at 41°C [98]. In another application, the same authors designed and fabricated a metallic structure with flagella that were loaded with lipoplexes containing pDNA. The results of the in vitro study revealed good delivery of the plasmids in human embryonic kidney cells. However, when translating this approach to an in vivo study, the potential cytotoxic issues due to the accumulated metals in non­targeted organs have to be taken into account [120]. Flexible magnetic MNR carriers were designed by Gao et al. to deliver microspheres made of PLGA containing drugs. The authors assessed the functionality of the MNR by delivering in vitro Dox to HeLa cancer cells. The main challenge, in this case, was the balance between the amount of drug and the capability of the engine to carry the load [118,121]. Worm-like MNRs have been developed by using rigid links connected with flexible joints for delivering drugs in
Table 2 Summary of the applications of MNRs based on the propulsion mechanisms. Propulsion Advantages Limitations Cargo Reference
119Biomaterials and devices for immunotherapy
Magnetic Work in
relative weak mag­netic field
Precise
navigation
Good
penetration
Electric
Energetic
source easily available
Precise
navigation
Structural
materials may harm living tissues
Electric fields
may harm living tissues
Weak
penetration
PLGA liposomes
charged with Dox and iron oxide
PLGA liposomes
charged with calcein
Liposomes with
calcein triggered by temperature variation
Lipoplexes containing
pDNA delivered in human embryonic kidney cells
PLGA Microspheres
with Dox for HeLa cancer cells
6-carboxyfluoresceins
for HeLa cancer cells
Dox for HeLa/
spheroid cancer cells
Dox triggered with
NIR light
Zeolitic-imidazole
framework-8 released via pH variation
Tissue plasminogen
activators (rtPA or tPA) in blood clots
Microvalves with 6-
carboxyfluorescein Not disclosed [100] Not disclosed [91,135] Nile Blue stains [136,1 37] Hydrophobic layer of
1-dodecanethiol to
absorb a tumor-
necrosis factor
[117]
[118,119]
[98]
[120]
[118,121]
[122]
[123–125]
[126–128]
[129]
[130–134]
[122]
[138]
Continued
120 Emily M. Jordan et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 2 Summary of the applications of MNRs based on the propulsion mechanismscontd Propulsion Advantages Limitations Cargo Reference
Light Good pen-
etration with NIR light
NIR light
used also as an effective trigger
Ultrasounds
Strong
penetration
Precise
navigation
Endogenous
Good
propulsion
No need of
external stimuli to propel the MNR
Weak penetra-
tion of tissues of visible light
Harmful
penetration of UV light
It requires a
magnetic field to steer MNRs
Ulltrasounds
may induce oxidative stress in living less
Structural
materials may harm living tissues
Less precision in
navigation than other mechanisms
Energy may be
insufficient for performing the envisaged task
Fuels not always
safe for living tissues
Not disclosed [139,140] Macrophage cell
membrane
Dox for HeLa cancers
cells triggered by a NIR light beam
pH-sensitive drug for
cancer cells
Brilliant green
antiseptic drug triggered by pH variation
pH-responsive
nanovalves to release insulin in
presence of glucose Not disclosed [147] Dox [148–150] Dox triggered by
ultrasounds on
HeLa cancer cells Fluorescein
isothiocyanate in
body fluids or blood
plasma Clarithromycin/
ampicillin to treat
bacterial infections Dox triggered by NIR
light Thrombin coagulant
for blood vessels α-toxin to neutralize
the Staphylococcus
aureus
Anti-CTLAA-4
antibodies in a
dermal melanoma
animal model
[141]
[142]
[105,143–145]
[110]
[146]
[151]
[152]
[153–155]
[115,151,156,157]
[158,159]
[160]
[161]
Dox, doxorubicin.
biological fluids. Propulsion was provided, for instance, by coating the links with mag­netic CoFe
nanoparticles. Mesoporous silica nanotubes have been used to create
2O4
linked structures for releasing 6-carboxyfluoresceins to HeLa tumor cell in vitro [122]. Surface magnetic walkers propelled by magnetic fields were developed by Sun et al. that encapsulated Fe
particles to interact with the external field, and Dox drug to be
3O4
delivered to HeLa cells in vitro [123]. The main limitation of magnetic-field-driven MNRs dwells in the potential immune reaction, which may lead to inflammations or other undesired effects in vivo, that can arise from the inclusion of metals required for the locomotion mechanism [162,163].
Superparamagnetic engines were arranged on a snake-like robot to capture cells and deliver Dox to cancer cells [124]. A 3D-printed biodegradable MNR made of chitosan and powered by a weak magnetic field was used to deliver tuned dosages of Dox with a NIR light [126]. Using gelatin methacryloyl as a structural material, other authors deliv­ered drugs exploiting the natural swelling of the polymer [164]. Magnetic propulsion has also been used for MNR swimmers in bloodstreams capable of finding cancer cells with specific antibodies. Dox is then release using NIR light [127,128]. Finally, other relevant applications of magnetic MNRs concern microhelices coated with a zeolitic-imidazole framework-8 that was released in environments with acidic pH [129], or nanotubes coated with magnetic particles for delivering Dox to spheroid tumors [125].
Magnetic NPs were driven to release tissue plasminogen activators (rtPA or tPA) in blood clots [130–132]. Since the presence of metallic MNRs in living bodies is consid­ered a potential issue, scientists have pushed for MNRs endowed with superparamagnetic materials to carry tPA through covalent bonds. They were tested to target blood clots in animal brains and activate chemical lyses [133]. MNRs used for kidney diseases were found easily collectable in urine using an external magnet [134].
121Biomaterials and devices for immunotherapy
6.2 Electric and piezoelectric MNRs
Electric-field driven MNRs have been used mainly for in vitro applications to test the transportation and releasing of cargos. Examples are catalytic nanomotors propelled by conditioning circuits [91] or rotational nanomotors made of carbon nanotubes with high responsiveness and movement speed [135]. Electric nanomotors have been used to carry Nile Blue stains through electrostatic interaction, which was efficiently released by exploiting the rotation of the engine itself. This experiment paved the way for future use in drug delivery based on a controlled rotation of the MNR rotor [136,137].
Electric nanoengines have been used to propel MNRs aimed at delivering tumor­necrosis factors. For instance, gold nanowires were coated with a hydrophobic layer of 1-dodecanethiol to absorb a tumor-necrosis factor. This eventually led to the activa­tion of the nuclear factor (kappa B transcription factor) inside cells, inducing an immune reaction [138].
122 Emily M. Jordan et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
A different approach to deliver drugs is the use of the piezoelectric effect. Poly­vinylidene fluoride (PVDF) is an electroactive polymer with excellent piezoelectric properties compared to other biocompatible polymers and easily shapeable on the nanoscale, for example as nanofibers [165]. Kapat et al. and Mushtaq et al. used PVDF-based copolymers in MNRs [166,167]. Mus htaq et al. developed a nanorobot that mimics an electric eel (namely, nanoeel) able to generate electricity upon move­ment. The nanoeel was made of a flexible PVDF tail, attached to a polypyrrole (Ppy) nanowire, finally decorated with a nickel ring for magnetic actuation. The magnetic head module was Ni-Ppy; it is able to oscillate upon alternating magnetic field appli­cation which causes the ferroelectric tail to flex and generate changes in its electrical polarization due to the piezoelectrical effect. The prepared hybrid nanoeels can be magnetically actuated and triggered for targeted and on-de mand drug delivery
[167].Chenet al. developed a wired-shaped magnetoelectric nanor obot, provided with
a magnetic core and piezoelectric shell structure [168]. T he authors demonstrated its wireless motion and release of the PTX drug on-site by using different magnetic fi eld modalities.
6.3 Light-driven MNRs
Zhan et al. designed a light-driven MNR by exploiting nanowire linear dichroism of Sb a nontoxic and highly biocompatible MNR that is activated by visible-light photo­catalysis and is able to perform movements in biological environments [140]. Xuan et al., instead, designed an MNR that changes the directionality of its movement when exposed to NIR light, exploiting the generated heat gradient to overcome the Brownian motion. The authors also coated the structure with macrophage cells, making the MNR able to actively detect and bind cancer cells [141].
and assessed their efficient locomotion [139]. In addition, Wang et al. developed
2Se3
6.4 Ultrasound-propelled MNRs
Victor et al. designed a four-segment MNR endowed with an Au-Ni-Au wire for ultra­sound, which can be steered by a directional magnetic field to deliver Dox-loaded NPs to HeLa cancer cells when triggered by an NIR light beam [142]. Another application con­sisted of delivering pH-sensitive drugs carried on a multisegment MNR in an acidic envi­ronment [105]. Ultrasound-propelled MNR was endowed with a Ppy-polystyrene sulfonate segment, holding, via electrostatic interactions, a brilliant green antiseptic drug, stable at pH 7, that was released when the environmental pH reduced to 4 [110]. pH-sensitive polymers have a remarkable efficiency on cancer cells since these cells are acidic targets [143–145]. Ultrasound was also used to propel a nanowire with pH-responsive nanovalves upon variation of the environmental pH [146].
6.5 Endogenous engines for MNRs
Microrockets fueled by oxygen peroxide were tested in vitro to carry Dox via π-π inter­actions induced by graphene oxide. The release of the drug was achieved by triggering an electrochemical stimulus that decoupled the holding interaction to the drug [147]. MNRs propelled by urea have been tested to deliver Dox [148]. Endogenous-propelled MNRs were assembled in a multilayer fashion (e.g., positively-charged chitosan over negatively-charge sodium alginate) in order to internalize Dox that will be eventually released via ultrasounds to HeLa cancer cells [151]. Alternative structures to perform the same task have been fabricated using gelatin. In this case, NIR light was used to trig­ger drug release [151,157]. Hydrogen peroxide was also used as a fuel to propel soft MNRs charged with platinum nanoparticles and Dox, eventually released by inducing a rupture of the PEG shell holding the cargo [115,156].
A more biocompatible solution to fuel MNRs is the employment of magnesium-
powered engines that have been usually coated with pH- or temperature-responsive polymer holding drugs. This approach has been validated in vitro by delivering fluorescein isothiocyanate in body fluids or blood plasma [152] or targeting in vivo areas of a mouse stomach with clarithromycin or ampicillin which serve to treat bacterial infections
[153–155]. Moreover, it has been demonstrated how the efficacy of Dox can be improved
with this biofuel due to a synergistic effect that occurs with the generation of hydrogen molecules on-site [149]. An MNR propelled by the results of the chemical degradation of carbonate and tranexamic acid was used to deliver a thrombin coagulant through blood vessels of animal models [158,159]. A self-propelled magnesium-based MNR was injected with a vaccine to deliver an α-toxin able to neutralize Staphylococcus aureus [160]. Magne­sium has also been used to propel MNR aimed at delivering anti-CTLAA-4 antibodies autonomously in a dermal melanoma animal model. The antibody could penetrate phan­tom tissues due to the force generated by hydrogen released when magnesium interacts with interstitial fluids [161]. Another alternative to hydrogen peroxide is a zinc/iron-based engine that has been used to deliver Dox in the gastrointestinal tract [150].
123Biomaterials and devices for immunotherapy
7. Conclusion and future outlook
In this chapter, nanobiomaterial-based strategies for the delivery of an immuno-
therapy agent with the delivery of a chemotherapy agent by itself (i.e., without bioma­terials) or biomaterial-based strategies for the dual delivery of both the immunotherapy and chemotherapy agents were discussed. The literature available demonstrated that the utilization of nanosized biomaterials, usually NPs, including nanospheres, nanorods, and other nanosized shapes, can greatly help to enhance the delivery and efficacy of the drug by protecting the agents, to increase targeting to the cells of interest, and tumor sites and to decrease nonspecific side effects and toxicity. There are several nanobiomaterial-based
124 Emily M. Jordan et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
strategies that were utilized to deliver a chemotherapy agent in combination with sys­temic delivery of immunotherapy (i.e., without biomaterials), however, they are beyond the scope of this chapter, as we focused on nanobiomaterials-based immunotherapies
[169–173]. To increase the antitumor effects of these strategies, both the immunotherapy
and chemotherapy agents should be administrated via biomaterials as they further serve as an agent to decrease the nontarget cytotoxic effect of the chemotherapy such as those on immune cells, ultimately avoiding immune suppression, supporting a healthy immune function and in turn helping to increase the response to the immunotherapy being deliv­ered. Several preclinical models indicate that the sequence of the combination therapy is critical and the delivery of chemotherapy first followed by immunotherapy appears to be the most effective way of combining both of these treatments [174,175]. Thus, well­designed NPs strategies should be developed to deliver these two agents at optimal times and doses to result in synergistic effects on antitumor activity. Another interesting class of polymer NPs, not yet widely exploited and potentially interesting in immunotherapy, are molecularly imprinted NPs, also known as synthetic antibodies [176]. Molecular imprinting allows NPs to display specific and selective cavities, having form, dimension, and chemical structure complementary to molecules or receptor sequences in order to obtain an efficient and selective recognition in vivo with drugs, ligands, or natural recep­tors involved in inflammation, infection, or altered processes. Major advantages in the use of molecularly imprinted NPs for coating with biological antibodies include the possi­bility of avoiding the use of natural proteins that can induce unwanted immunological responses [177].
We also focused part of this chapter on special biomaterial-based objects provided with a propulsion system to allow precise local targeting. Such ultra-small size devices are named MNRs and are becoming very attractive for drug delivery, in particular in those applications in which precision and noninvasiveness are strict requirements for effi­cient therapy. Being able to access parts of the body that are hard to reach, by using MNRs physicians could perform medical treatments on specific targets without affecting healthy tissues. In contrast to passive devices, such as scaffolds or nonactuating NPs, MNRs can be guided through living tissues by means of a propulsion system that, in most cases, is triggered by external stimuli. However, besides the unquestionable advantages of MNRs, still many challenges have to be faced and solutions have to be found to improve these devices. A first issue is related to the biocompatibility of MNRs that, being often made of metals to ensure responsiveness from electromagnetic fields, may induce inflam­mations or immune reactions [178,179]. In contrast, devices made of biocompatible polymers are usually triggered by stimuli that cannot penetrate living tissues efficiently or, worse, may induce excessive stress on cellular structures. However, sometimes, the driving mechanism used to direct the MNRs to the target organ can be also exploited to conduct these objects to the excretory systems, thus facilitating their expulsion and minimizing their toxicity. The abovementioned disadvantages have limited the investi­gation on the applicability of MNRs in vivo, restricting most of the studies on in vitro